Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
94
TALK Quote, Financials, Valuation and Earnings
Last price:
$3.64
Seasonality move
:
18.89%
Day range:
$3.54 - $3.65
52-week range:
$2.22 - $4.36
Dividend yield:
0%
P/E ratio:
145.31x
P/S ratio:
2.87x
P/B ratio:
5.41x
Volume:
627.8K
Avg. volume:
1.1M
1-year change:
12.3%
Market cap:
$589.7M
Revenue:
$187.6M
EPS (TTM):
$0.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TALK
Talkspace, Inc.
|
$61.9M | $0.02 | 27.09% | 44.93% | $4.86 |
|
AMS
American Shared Hospital Services
|
$8.8M | $0.02 | -3.19% | -100% | $4.50 |
|
CCEL
Cryo-Cell International, Inc.
|
$7.7M | -$0.09 | -4.04% | -60.92% | $8.50 |
|
MRAI
Marpai, Inc.
|
$8.7M | -$0.43 | -10.05% | -74.41% | -- |
|
NHC
National HealthCare Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TALK
Talkspace, Inc.
|
$3.56 | $4.86 | $589.7M | 145.31x | $0.00 | 0% | 2.87x |
|
AMS
American Shared Hospital Services
|
$2.11 | $4.50 | $13.8M | 11.73x | $0.00 | 0% | 0.47x |
|
CCEL
Cryo-Cell International, Inc.
|
$3.40 | $8.50 | $27.4M | 498.00x | $0.15 | 19.12% | 0.87x |
|
MRAI
Marpai, Inc.
|
$0.64 | -- | $6.6M | -- | $0.00 | 0% | 0.48x |
|
NHC
National HealthCare Corp.
|
$138.41 | -- | $2.1B | 21.35x | $0.64 | 1.81% | 1.45x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TALK
Talkspace, Inc.
|
-- | 0.631 | -- | 5.71x |
|
AMS
American Shared Hospital Services
|
50.05% | 0.126 | 110.57% | 1.02x |
|
CCEL
Cryo-Cell International, Inc.
|
-564.01% | 1.723 | 33.28% | 0.78x |
|
MRAI
Marpai, Inc.
|
-47.21% | 2.591 | 76.28% | 0.51x |
|
NHC
National HealthCare Corp.
|
10.84% | 1.073 | 7.3% | 1.23x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TALK
Talkspace, Inc.
|
$24M | $2.2M | 3.72% | 3.72% | 3.7% | $1.9M |
|
AMS
American Shared Hospital Services
|
$1.6M | $48K | -6.67% | -12.09% | 0.67% | -$2M |
|
CCEL
Cryo-Cell International, Inc.
|
$5.8M | $1.9M | -20.01% | -- | 24.29% | $2.5M |
|
MRAI
Marpai, Inc.
|
$967K | -$2.8M | -- | -- | -68.64% | $634K |
|
NHC
National HealthCare Corp.
|
$131.4M | -$87.2M | 8.6% | 10.22% | -22.9% | $56.5M |
Talkspace, Inc. vs. Competitors
-
Which has Higher Returns TALK or AMS?
American Shared Hospital Services has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of -4.59%. Talkspace, Inc.'s return on equity of 3.72% beat American Shared Hospital Services's return on equity of -12.09%.
Company Gross Margin Earnings Per Share Invested Capital TALKTalkspace, Inc.40.34% $0.02 $109.1M AMSAmerican Shared Hospital Services21.94% -$0.00 $53.2M -
What do Analysts Say About TALK or AMS?
Talkspace, Inc. has a consensus price target of $4.86, signalling upside risk potential of 36.44%. On the other hand American Shared Hospital Services has an analysts' consensus of $4.50 which suggests that it could grow by 113.27%. Given that American Shared Hospital Services has higher upside potential than Talkspace, Inc., analysts believe American Shared Hospital Services is more attractive than Talkspace, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TALKTalkspace, Inc.6 1 0 AMSAmerican Shared Hospital Services0 0 0 -
Is TALK or AMS More Risky?
Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.122, suggesting its less volatile than the S&P 500 by 87.793%.
-
Which is a Better Dividend Stock TALK or AMS?
Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TALK or AMS?
Talkspace, Inc. quarterly revenues are $59.4M, which are larger than American Shared Hospital Services quarterly revenues of $7.2M. Talkspace, Inc.'s net income of $3.3M is higher than American Shared Hospital Services's net income of -$329K. Notably, Talkspace, Inc.'s price-to-earnings ratio is 145.31x while American Shared Hospital Services's PE ratio is 11.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.87x versus 0.47x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TALKTalkspace, Inc.2.87x 145.31x $59.4M $3.3M AMSAmerican Shared Hospital Services0.47x 11.73x $7.2M -$329K
-
Which has Higher Returns TALK or CCEL?
Cryo-Cell International, Inc. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of 9.58%. Talkspace, Inc.'s return on equity of 3.72% beat Cryo-Cell International, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TALKTalkspace, Inc.40.34% $0.02 $109.1M CCELCryo-Cell International, Inc.74.61% $0.09 -$2.2M -
What do Analysts Say About TALK or CCEL?
Talkspace, Inc. has a consensus price target of $4.86, signalling upside risk potential of 36.44%. On the other hand Cryo-Cell International, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 150%. Given that Cryo-Cell International, Inc. has higher upside potential than Talkspace, Inc., analysts believe Cryo-Cell International, Inc. is more attractive than Talkspace, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TALKTalkspace, Inc.6 1 0 CCELCryo-Cell International, Inc.0 1 0 -
Is TALK or CCEL More Risky?
Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison Cryo-Cell International, Inc. has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.089%.
-
Which is a Better Dividend Stock TALK or CCEL?
Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International, Inc. offers a yield of 19.12% to investors and pays a quarterly dividend of $0.15 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Cryo-Cell International, Inc. pays out 510.2% of its earnings as a dividend.
-
Which has Better Financial Ratios TALK or CCEL?
Talkspace, Inc. quarterly revenues are $59.4M, which are larger than Cryo-Cell International, Inc. quarterly revenues of $7.8M. Talkspace, Inc.'s net income of $3.3M is higher than Cryo-Cell International, Inc.'s net income of $749.4K. Notably, Talkspace, Inc.'s price-to-earnings ratio is 145.31x while Cryo-Cell International, Inc.'s PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.87x versus 0.87x for Cryo-Cell International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TALKTalkspace, Inc.2.87x 145.31x $59.4M $3.3M CCELCryo-Cell International, Inc.0.87x 498.00x $7.8M $749.4K
-
Which has Higher Returns TALK or MRAI?
Marpai, Inc. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of -86.55%. Talkspace, Inc.'s return on equity of 3.72% beat Marpai, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TALKTalkspace, Inc.40.34% $0.02 $109.1M MRAIMarpai, Inc.23.95% -$0.20 -$22.7M -
What do Analysts Say About TALK or MRAI?
Talkspace, Inc. has a consensus price target of $4.86, signalling upside risk potential of 36.44%. On the other hand Marpai, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Talkspace, Inc. has higher upside potential than Marpai, Inc., analysts believe Talkspace, Inc. is more attractive than Marpai, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TALKTalkspace, Inc.6 1 0 MRAIMarpai, Inc.0 0 0 -
Is TALK or MRAI More Risky?
Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison Marpai, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock TALK or MRAI?
Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marpai, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Marpai, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TALK or MRAI?
Talkspace, Inc. quarterly revenues are $59.4M, which are larger than Marpai, Inc. quarterly revenues of $4M. Talkspace, Inc.'s net income of $3.3M is higher than Marpai, Inc.'s net income of -$3.5M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 145.31x while Marpai, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.87x versus 0.48x for Marpai, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TALKTalkspace, Inc.2.87x 145.31x $59.4M $3.3M MRAIMarpai, Inc.0.48x -- $4M -$3.5M
-
Which has Higher Returns TALK or NHC?
National HealthCare Corp. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of 10.77%. Talkspace, Inc.'s return on equity of 3.72% beat National HealthCare Corp.'s return on equity of 10.22%.
Company Gross Margin Earnings Per Share Invested Capital TALKTalkspace, Inc.40.34% $0.02 $109.1M NHCNational HealthCare Corp.34.5% $2.51 $1.2B -
What do Analysts Say About TALK or NHC?
Talkspace, Inc. has a consensus price target of $4.86, signalling upside risk potential of 36.44%. On the other hand National HealthCare Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Talkspace, Inc. has higher upside potential than National HealthCare Corp., analysts believe Talkspace, Inc. is more attractive than National HealthCare Corp..
Company Buy Ratings Hold Ratings Sell Ratings TALKTalkspace, Inc.6 1 0 NHCNational HealthCare Corp.0 0 0 -
Is TALK or NHC More Risky?
Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison National HealthCare Corp. has a beta of 0.654, suggesting its less volatile than the S&P 500 by 34.582%.
-
Which is a Better Dividend Stock TALK or NHC?
Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National HealthCare Corp. offers a yield of 1.81% to investors and pays a quarterly dividend of $0.64 per share. Talkspace, Inc. pays -- of its earnings as a dividend. National HealthCare Corp. pays out 37.04% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TALK or NHC?
Talkspace, Inc. quarterly revenues are $59.4M, which are smaller than National HealthCare Corp. quarterly revenues of $380.8M. Talkspace, Inc.'s net income of $3.3M is lower than National HealthCare Corp.'s net income of $41M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 145.31x while National HealthCare Corp.'s PE ratio is 21.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.87x versus 1.45x for National HealthCare Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TALKTalkspace, Inc.2.87x 145.31x $59.4M $3.3M NHCNational HealthCare Corp.1.45x 21.35x $380.8M $41M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
FTAI alert for Dec 31
FTAI Aviation Ltd. [FTAI] is down 0.38% over the past day.
Sell
45
LYEL alert for Dec 31
Lyell Immunopharma, Inc. [LYEL] is down 2.63% over the past day.
Sell
36
CORT alert for Dec 31
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
